{
  "retracted": false,
  "timestamp": 1552521600000,
  "updates": [
    {
      "timestamp": 1574891487584,
      "identifier": {
        "doi": "10.1186/s40425-019-0559-3"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1186/s40425-018-0420-0"
  },
  "journal": "Journal for ImmunoTherapy of Cancer",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study"
}
